Drug Profile
Oxybutynin transdermal gel - Antares
Alternative Names: Anturol; AP-1034; Gelnique 3% Gel; Oxybutynin ATD™ gelLatest Information Update: 26 May 2022
Price :
$50
*
At a glance
- Originator Antares Pharma
- Developer AbbVie; Antares Pharma
- Class Alkynes; Antispasmodics; Carbocyclic acids; Cyclohexanes; Diethylamines; Esters; Mandelic acids; Skin disorder therapies; Small molecules
- Mechanism of Action Cholinergic receptor antagonists; Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Marketed Overactive bladder